The present disclosure relates to compounds of formula (II):
pharmaceutical compositions comprising same and use of the compounds and compositions for the treatment of microbial infection, particularly Methicillin-resistant
Staphylococcus aureus
(MRSA) infection.
本公开涉及化合物的公式(II):包括相同的药物组合物以及用于治疗微
生物感染,特别是耐
甲氧西林金黄色葡萄球菌(MRSA)感染的化合物和组合物的用途。